125 related articles for article (PubMed ID: 17442023)
1. Autoantibody profile in the experimental model of scleroderma induced by type V human collagen.
Callado MR; Viana VS; Vendramini MB; Leon EP; Bueno C; Velosa AP; Teodoro WR; Yoshinari NH
Immunology; 2007 Sep; 122(1):38-46. PubMed ID: 17442023
[TBL] [Abstract][Full Text] [Related]
2. Collagen V nasal tolerance in experimental model of systemic sclerosis.
Velosa AP; Teodoro WR; de Oliveira CC; Dos Santos Filho A; Moutinho RF; Santos AG; Vendramini MB; Bueno C; Parra ER; Capelozzi VL; Yoshinari NH
Arch Dermatol Res; 2007 Jul; 299(4):177-89. PubMed ID: 17297604
[TBL] [Abstract][Full Text] [Related]
3. Scleroderma-like remodeling induced by type V collagen.
Bezerra MC; Teodoro WR; de Oliveira CC; Velosa AP; Ogido LT; Gauditano G; Parra ER; Capelozzi VL; Yoshinari NH
Arch Dermatol Res; 2006 Jul; 298(2):51-7. PubMed ID: 16710740
[TBL] [Abstract][Full Text] [Related]
4. Proposition of a novel animal model of systemic sclerosis induced by type V collagen in C57BL/6 mice that reproduces fibrosis, vasculopathy and autoimmunity.
Teodoro WR; de Jesus Queiroz ZA; Dos Santos LA; Catanozi S; Dos Santos Filho A; Bueno C; Vendramini MBG; Fernezlian SM; Eher EM; Sampaio-Barros PD; Pasoto SG; Lopes FDTQS; Velosa APP; Capelozzi VL
Arthritis Res Ther; 2019 Dec; 21(1):278. PubMed ID: 31829272
[TBL] [Abstract][Full Text] [Related]
5. Abnormal collagen deposition in synovia after collagen type V immunization in rabbits.
Ogido LT; Teodoro WR; Velosa AP; de Oliveira CC; Parra ER; Capelozzi VL; Yoshinari NH
Histol Histopathol; 2008 Mar; 23(3):263-9. PubMed ID: 18072083
[TBL] [Abstract][Full Text] [Related]
6. Histomorphometric analysis of cutaneous remodeling in the early stage of the scleroderma model.
de Oliveira CC; Velosa AP; Parra ER; Capelozzi VL; Teodoro WR; Yoshinari NH
Clinics (Sao Paulo); 2009; 64(6):577-83. PubMed ID: 19578663
[TBL] [Abstract][Full Text] [Related]
7. Immunization with DNA topoisomerase I and Freund's complete adjuvant induces skin and lung fibrosis and autoimmunity via interleukin-6 signaling.
Yoshizaki A; Yanaba K; Ogawa A; Asano Y; Kadono T; Sato S
Arthritis Rheum; 2011 Nov; 63(11):3575-85. PubMed ID: 21792823
[TBL] [Abstract][Full Text] [Related]
8. Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis.
Costa S; Mondini M; Caneparo V; Afeltra A; Airò P; Bellisai F; Faggioli P; Gerli R; Lotzniker M; Meroni PL; Morozzi G; Radice A; Riccieri V; Scarsi M; Sebastiani GD; Sinico RA; Tincani A; Gariglio M; Landolfo S
Rheumatology (Oxford); 2011 Apr; 50(4):674-81. PubMed ID: 21134960
[TBL] [Abstract][Full Text] [Related]
9. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
Hamaguchi Y
J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
[TBL] [Abstract][Full Text] [Related]
10. Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis.
Hénault J; Tremblay M; Clément I; Raymond Y; Senécal JL
Arthritis Rheum; 2004 Oct; 50(10):3265-74. PubMed ID: 15476238
[TBL] [Abstract][Full Text] [Related]
11. Clinical features of Japanese systemic sclerosis (SSc) patients negative for SSc-related autoantibodies: A single-center retrospective study.
Miyake M; Matsushita T; Takehara K; Hamaguchi Y
Int J Rheum Dis; 2020 Aug; 23(9):1219-1225. PubMed ID: 32662135
[TBL] [Abstract][Full Text] [Related]
12. Autoantibody profile in systemic sclerosis as a marker for esophageal and other organ involvement in Turkish populations.
Savas N; Dagli U; Ertugrul E; Kuran S; Sahin B
Dig Dis Sci; 2007 Nov; 52(11):3081-6. PubMed ID: 17393310
[TBL] [Abstract][Full Text] [Related]
13. Autoantibody against matrix metalloproteinase-3 in patients with systemic sclerosis.
Nishijima C; Hayakawa I; Matsushita T; Komura K; Hasegawa M; Takehara K; Sato S
Clin Exp Immunol; 2004 Nov; 138(2):357-63. PubMed ID: 15498049
[TBL] [Abstract][Full Text] [Related]
14. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
Russo K; Hoch S; Dima C; Varga J; Teodorescu M
J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
[TBL] [Abstract][Full Text] [Related]
15. Immunization with DNA topoisomerase I induces autoimmune responses but not scleroderma-like pathologies in mice.
Hu PQ; Hurwitz AA; Oppenheim JJ
J Rheumatol; 2007 Nov; 34(11):2243-52. PubMed ID: 17937466
[TBL] [Abstract][Full Text] [Related]
16. Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases.
Shovman O; Gilburd B; Zandman-Goddard G; Yehiely A; Langevitz P; Shoenfeld Y
Autoimmunity; 2005 Feb; 38(1):105-9. PubMed ID: 15804711
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of three methods for the detection of anti-SCL70 autoantibodies].
Yalaoui S; Gorgi Y; Ayed K
Ann Biol Clin (Paris); 2001; 59(5):639-42. PubMed ID: 11602398
[No Abstract] [Full Text] [Related]
18. Induction of interferon-alpha by scleroderma sera containing autoantibodies to topoisomerase I: association of higher interferon-alpha activity with lung fibrosis.
Kim D; Peck A; Santer D; Patole P; Schwartz SM; Molitor JA; Arnett FC; Elkon KB
Arthritis Rheum; 2008 Jul; 58(7):2163-73. PubMed ID: 18576347
[TBL] [Abstract][Full Text] [Related]
19. DNA topoisomerase I binding to fibroblasts induces monocyte adhesion and activation in the presence of anti-topoisomerase I autoantibodies from systemic sclerosis patients.
Hénault J; Robitaille G; Senécal JL; Raymond Y
Arthritis Rheum; 2006 Mar; 54(3):963-73. PubMed ID: 16508979
[TBL] [Abstract][Full Text] [Related]
20. Anti-topoisomerase I autoantibodies in systemic sclerosis.
Czömpöly T; Simon D; Czirják L; Németh P
Autoimmun Rev; 2009 Jul; 8(8):692-6. PubMed ID: 19393194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
